Discipline and Rules-Based Execution in FIGS Response
This article analyzes Figs Inc. Class A (NASDAQ: FIGS) using AI models, highlighting a positive near-term sentiment that may counter a mid-term weak bias within a long-term strong context. It identifies resistance testing, an exceptional short setup, and outlines three distinct trading strategies (Position, Momentum Breakout, and Risk Hedging) with specific entry, target, and stop-loss levels. The analysis also provides multi-timeframe signal analysis for near-term, mid-term, and long-term horizons, indicating support and resistance levels.
Insider Sale: Executive Chair of $FIGS Sells 22,874 Shares
Heather L. Hasson, the Executive Chair of FIGS, sold 22,874 shares of the company on February 5, 2026, for an estimated $241,549. This sale represents approximately 1.8% of her holdings, bringing her total to 1,251,967 shares. The article also details other insider trading activity, hedge fund movements, recent revenue figures, and analyst ratings for FIGS.
Behavioral Patterns of FIGS and Institutional Flows
This article analyzes Figs Inc. Class A (NASDAQ: FIGS) using AI models to provide trading strategies. It highlights weak near to mid-term sentiment but a strong long-term outlook, identifying resistance being tested and suggesting support levels. The analysis includes position, momentum breakout, and risk hedging strategies with specific entry, target, and stop-loss zones.
FIGS Olympic Push With Lindsey Vonn Tests Premium Valuation Narrative
FIGS (NYSE:FIGS) has partnered with Olympic skier Lindsey Vonn and extended its collaboration with the US Olympic & Paralympic Committee through the LA 2028 Games, introducing a limited edition healthcare apparel collection. This move aims to leverage global visibility from major sporting events to deepen engagement with healthcare professionals, especially as the stock is currently trading above analyst targets and estimated fair value. Investors are keen to see if this exposure translates into customer conversion and justifies its high P/E ratio.
(FIGS) Movement Within Algorithmic Entry Frameworks
This article analyzes Figs Inc. Class A (NASDAQ: FIGS) using algorithmic entry frameworks, highlighting weak near and mid-term sentiment but a strong long-term outlook. It presents specific trading strategies (Position, Momentum Breakout, Risk Hedging) with entry zones, targets, and stop losses, based on AI-generated signals and multi-timeframe analysis. The analysis also identifies a significant risk-reward short setup.
How (FIGS) Movements Inform Risk Allocation Models
This article analyzes Figs Inc. Class A (NASDAQ: FIGS) using AI models to provide trading strategies. It highlights a near-term strong sentiment potentially leading to a long-term positive bias, with resistance being tested. The analysis includes position trading, momentum breakout, and risk hedging strategies for different risk profiles.
Trading Systems Reacting to (FIGS) Volatility
The article discusses how trading systems are reacting to volatility in Figs Inc. Class A (NASDAQ: FIGS) stock, noting divergent sentiment across all horizons and a breakout underway. It provides AI-generated trading strategies for different risk profiles, including position trading, momentum breakout, and risk hedging strategies, along with multi-timeframe signal analysis. The piece highlights elevated downside risk as no additional long-term support signals remain.
Avoiding Lag: Real-Time Signals in (FIGS) Movement
This article analyzes Figs Inc. Class A (NASDAQ: FIGS) using AI models, indicating strong sentiment across all horizons but elevated downside risk. It provides three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored to different risk profiles. The analysis includes real-time signals, multi-timeframe signal strengths, and support/resistance levels to optimize position sizing and manage risk.
(FIGS) Risk Channels and Responsive Allocation
This article analyzes Figs Inc. Class A (NASDAQ: FIGS), highlighting strong sentiment across all horizons and an overweight bias, despite elevated downside risk in the long term. It provides three AI-generated trading strategies: Long Position, Momentum Breakout, and Risk Hedging, along with a multi-timeframe signal analysis. The analysis is based on predictive AI models from Stock Traders Daily.
$FIGS stock is up 9% today. Here's what we see in our data. | FIGS Stock News
FIGS stock is up 9% today with significant trading volume. Insider trading data shows seven sales and no purchases in the last six months by top executives. Institutional holdings data reveals mixed sentiment, with 92 investors increasing their positions and 109 decreasing them in the last quarter, while analyst ratings are split between "Buy" and "Sell" with a median price target of $9.0.
FIGS (NYSE:FIGS) Shares Tick Higher on Sector-Focused Trade
This article provides a detailed overview of FIGS (NYSE:FIGS) within the apparel sector, highlighting its focus on garments designed for healthcare environments. It discusses the company's product offerings, including scrubwear, outer garments, and accessories, and emphasizes its structured design process focused on comfort and material performance. The full article content requires a user login or account creation to access.
Why The Story Behind FIGS Is Changing After Recent Analyst and Business Updates
FIGS (NYSE:FIGS) has seen its consensus analyst price target increase from $6.74 to $7.74 per share due to improving growth expectations, brand strength, and a flexible financial position. While bullish analysts highlight strong brand position and operational momentum, bearish analysts like Goldman Sachs maintain caution due to valuation concerns and competitive pressures. The company also announced updated 2025 earnings guidance, an expanded partnership with Team USA for the Milano Cortina 2026 Winter Games, and introduced a new fabric innovation, FIBREx.
FIGS (NYSE: FIGS) raises 2025 outlook: ~7% revenue growth, ~10.3% adjusted EBITDA margin
FIGS, Inc. (NYSE: FIGS) reported strong Q3 2025 financial results with net revenues increasing by 8.2% to $151.7 million and adjusted EBITDA margin reaching 12.4%. The company also raised its full-year 2025 outlook, now expecting approximately 7.0% revenue growth and an adjusted EBITDA margin of about 10.3%, exceeding previous expectations due to consistent performance and strong fourth-quarter positioning.
Figs CFO Oughtred sells $168,015 in shares
FIGS, Inc. CFO Sarah Oughtred sold 22,745 shares of Class A Common Stock for $168,015 to cover taxes related to RSU vesting. Despite the sale, Oughtred retains significant holdings, and the company demonstrates strong financial health with high gross profit margins and a cash-rich balance sheet. The transaction follows recent positive financial reports for Figs, with Q2 2025 earnings exceeding forecasts and analysts raising price targets.
Understanding Momentum Shifts in (FIGS)
This article provides an analysis of Figs Inc. Class A (NASDAQ: FIGS), highlighting strong sentiment across all horizons despite elevated downside risk due to a lack of long-term support signals. It offers three distinct AI-generated institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis, including support and resistance levels. The report emphasizes real-time signals, risk management, and personalized alerts available through their platform.
Insider Sale: Chief Executive Officer of $FIGS Sells 62,213 Shares | FIGS Stock News
The Chief Executive Officer of FIGS, Catherine Eva Spear, sold 62,213 shares of $FIGS stock for an estimated $428,081 on October 2, 2025. This sale represents approximately 3.2% of her holdings, leaving her with 1,907,033 shares. The article also details recent insider trading activity by other FIGS executives, hedge fund movements, and current analyst ratings and price targets for the stock.
FIGS, Inc. Stock (FIGS) Opinions on Analyst Ratings and Price Volatility
Discussions surrounding FIGS, Inc. (FIGS) are centered on recent analyst ratings and the stock's price movements, particularly a "Sell" rating from major financial firms. The healthcare apparel company's stock has shown pre-market dips and volatility, sparking debates among investors about its short-term future. Insider trading shows two sales by an executive while institutional investors show a mixed sentiment with more decreases than increases in positions held.
FIGS Stock Price, News & Analysis
FIGS, Inc. (NYSE: FIGS) is a direct-to-consumer healthcare apparel and lifestyle brand specializing in technically advanced products for healthcare professionals. The company operates globally through its digital platforms, targeting both individual professionals and institutions, and measures performance using metrics like active customers, net revenues per active customer, and average order value. FIGS emphasizes its brand identity through community connections, strategic partnerships like with Team USA, and regular financial reporting, while also highlighting the inherent risks in forward-looking statements.
FIGS LAWSUIT ALERT: Levi & Korsinsky Notifies FIGS, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Levi & Korsinsky, LLP has notified investors of FIGS, Inc. (NYSE: FIGS) about a class action lawsuit filed against the company. The lawsuit alleges that FIGS made false statements regarding its ability to secure repeat customers, its dependence on air freight, and its inflated financial projections for 2022. Investors who purchased FIGS securities between May 27, 2021, and May 12, 2022, have until January 3, 2023, to request to be appointed as lead plaintiff.
Scrubs maker FIGS valued at $4.57 bln in stellar debut
FIGS Inc. made a stellar market debut, with its shares jumping nearly 29% and valuing the company at $4.57 billion, following increased demand for medical apparel during the COVID-19 pandemic. The listing was notable as the first on Robinhood's platform, offering retail investors access to the IPO. Co-founders Trina Spear and Heather Hasson plan to use the raised funds to invest in new products, marketing, and data analytics.
Not your grandparents’ scrubs: Trendy medical-wear retailer Figs goes public
Figs, an online medical-wear retailer specializing in trendy scrubs, went public on the NYSE, experiencing a significant growth spurt fueled by the pandemic and social media marketing. The company's IPO saw shares priced at $22 and closing at $30.02, giving it a market cap of approximately $4.8 billion. Despite facing competition and a lawsuit, Figs attributes its success to its fashion-forward designs, high-tech fabrics, and corporate philanthropy.
Figs Stands Out Amidst A Sea Of Overvalued IPOs
Figs (FIGS), an apparel company for healthcare workers, is highlighted as a rare high-quality IPO in 2021, particularly appealing given its inclusion in Robinhood’s new IPO Access offering. The company demonstrated strong revenue growth and profitability in 2019 and 2020 through its direct-to-consumer model and efficient customer acquisition, operating in a large and growing market with high margins. Despite its promising financials and reasonable valuation compared to other recent IPOs, investors are cautioned about red flags such as diminished public shareholder rights, the sale of shares primarily by existing shareholders, and ongoing lawsuits concerning marketing claims.
Figs stock is available to request on Robinhood before it debuts on the NYSE
Healthcare apparel startup Figs is making its market debut on the NYSE this week, following a banner year in 2020 with net revenue climbing to $263.1 million. For the first time, Robinhood is allowing retail investors to request Figs shares at the IPO price through its new "IPO Access" tool, aiming to democratize access to initial public offerings. Figs is offering 22,500,000 shares of its Class A common stock at $16 to $19 per share, valuing the company at over $3 billion.
Figs IPO: 5 things to know about the newly-public healthcare apparel company
Figs Inc., an apparel and lifestyle company for healthcare workers, went public this week. The company priced its initial public offering at $22 a share, well above its expected range, and expanded its stock offering to raise nearly $581 million. Figs was founded eight years ago, with co-founders initially selling products out of their cars.
FIGS Is Going Public: Details About Its IPO Date and Price
Medical apparel company FIGS is going public with an IPO on the NYSE, seeking a $3 billion valuation. The company, which manufactures scrubs with proprietary fabric technology, is profitable, reporting $57.9 million in profit for 2020. Uniquely, FIGS will be the first company to offer some IPO shares to retail investors through Robinhood before its market debut on May 27.
FIGS Sued Over Antimicrobial Scrub Claims
A class action lawsuit has been filed against FIGS, Inc., alleging false advertising regarding their scrubs and lab coats being "antimicrobial" and capable of killing bacteria on contact. The lawsuit claims FIGS inflated prices based on these unfounded assertions, creating a health risk and misleading medical professionals. The investigation into this matter has been completed, and the lawsuit was dismissed on February 12, 2020.
Scrubs Brand Figs Sued by Competitor
Medical-uniform company Figs is being sued by competitor Strategic Partners, Inc. (SPI) for false advertising and unfair business practices in Los Angeles Superior Court and a similar suit in the U.S. District Court. SPI alleges that Figs' co-founder, Trina Spear, stole trade secrets while working at Blackstone, which was considering an SPI transaction. Figs' co-CEO, Heather Hasson, dismisses the lawsuits as "meritless," asserting they are a desperate attempt by an entrenched rival to protect market share against Figs' innovation in the scrubs market.
FIGS Class Action Says Scrubs Aren’t Antimicrobial
A class action lawsuit has been filed against FIGS medical apparel company, alleging that their scrubs are not antimicrobial as advertised. Plaintiff Avegail Torres claims that FIGS falsely marketed its scrubs as containing silver ions that kill bacteria and infections on contact, leading her to purchase expensive apparel under false pretenses. The lawsuit also raises concerns about potential health risks to patients and medical professionals due to the alleged misrepresentation.
FIGS Co-Founder Trina Spear Named to Aspen Institute's 2018 Class of Henry Crown Fellows
Trina Spear, co-founder and co-CEO of FIGS, has been selected as one of 22 business leaders under 45 for The Aspen Institute's 2018 Henry Crown Fellowship. This program aims to mobilize leaders to address global problems, encouraging them to move "from success to significance" through individual initiatives. Spear's company, FIGS, has revolutionized the medical apparel industry with its direct-to-consumer model and impressive growth, while also contributing to healthcare access globally through its "Threads for Threads" initiative.
